openPR Logo
Press release

Global HIV Diagnosis Market Analysis By Top Vendors like Siemens, Roche, Abbott, Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, Bio-Rad Laboratories, Hologic, Inc., QIAGEN

10-02-2018 10:10 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global HIV Diagnosis Market

Global HIV Diagnosis Market

Global HIV Diagnosis Market, By Product Type (Consumables, Assay, Kits, and Reagents, Other Consumables, Instruments, Software and Services), Test (Antibody {ELISA, Rapid, Western Blot}, Viral Load, CD4 Count, Early Infant, Viral Identification,), Product (Assay, Kit, Reagent, Instrument, Software, Services), End-Users (Diagnostic Laboratories, Hospitals, Research Institutes, Others), Geography- Industry Trends and Forecast to 2024.
HIV diagnosis is used for the diagnosis of the Human Immunodeficiency Virus (HIV) which is retrovirus that attacks the immune system of humans and weakens the person’s defense system against infections.

Download Free PDF Sample Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-hiv-diagnosis-market

Key Insights in the report:

• Historical and current market size and projection up to 2024
• Market trends impacting the growth of the global IoT sensors market
• Analyze and forecast the IoT sensors market on the basis of services, end-user, and services

Major Market Drivers & Restraints:

• Increasing healthcare expenditure on HIV
• Increasing prevalence of HIV/AIDS
• Increasing number of blood transfusions and blood donations
• Government Initiatives
• Growing technological advancement
• Strict regulatory scenario

Market Segmentation: Global HIV Diagnosis Market

By product type

• Consumables,
• Assay, Kits and reagents,
• Other consumables,
• Instruments,
• Software
• Services.

By test

• Antibody tests,
• CD4 count,
• Viral load,
• Early infant
• Viral identification.

Antibody tests

• ELISA,
• Rapid,
• Western blot.

By product

• Assay,
• Kit,
• Reagent,
• Instrument,
• Software
• Services.

On the basis of end-users

• diagnostic laboratories,
• Hospitals,
• Research institutes and others

Some of the major players operating in global HIV diagnosis market are

Siemens AG, F. Hoffmann-La Roche AG., Abbott, Danaher, Thermo Fisher Scientific, Inc., Merck KGaA, BD, Bio-Rad Laboratories, Hologic, Inc., QIAGEN, bioMerieux SA, Alere Inc., AbbVie Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Zyomyx Inc., PointCare, Sysmex Partec GmbH, Apogee Flow Systems Ltd, Sysmex Corporation, and ViiV Healthcare group of companies , Gilead, Quest Diagnostics Incorporated, Agilent Technologies among others.

For More Inquiry Contact us at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hiv-diagnosis-market

On the basis of geography Global HIV diagnosis market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Competitive Analysis: Global HIV Diagnosis Market

The global HIV diagnosis market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of HIV diagnosis market for global, Europe, North America, Asia Pacific and South America.

Market Analysis: Global HIV Diagnosis Market

The Global HIV Diagnosis Market accounted to USD 2.25 billion in 2016 growing at a CAGR of 10.4% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Detailed TOC at https://databridgemarketresearch.com/toc/?dbmr=global-hiv-diagnosis-market

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global HIV Diagnosis Market Analysis By Top Vendors like Siemens, Roche, Abbott, Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, Bio-Rad Laboratories, Hologic, Inc., QIAGEN here

News-ID: 1275640 • Views:

More Releases from Data Bridge Market Research

Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 to 2029
Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 t …
Precision gearbox market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to reach at an estimated value of USD 5.9 billion by 2029 and grow at a CAGR of 9.1% in the above-mentioned forecast period. Market Overview This precision gearbox market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecas …
Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031. Market Overview Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind
Radiology market registering a CAGR of 6.20% during the forecast period of 2022-2029
Radiology market registering a CAGR of 6.20% during the forecast period of 2022- …
Radiology market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Market Overview Radiology (also referred as diagnostic imaging) includes multiple tests are included in the process, which
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportun …
Global Cervical Retractors Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Cervical Retractors market is supposed to grow during the forecast period due to growing demand

All 5 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral